Related Experiment Videos
Intravascular aggregation after acute intracranial hypertension by epidural balloon compression in cats
Insights
Dextran 75 infusion improved cerebral perfusion and restored neurological function after acute intracranial hypertension in cats. This treatment mitigated microcirculatory disturbances by inhibiting platelet activation and improving blood flow.
Area of Science:
- Neuroscience
- Hematology
- Physiology
Background:
- Acute intracranial hypertension impairs cerebral perfusion and neurological function.
- Hematological changes, including platelet activation and reduced erythrocyte deformability, contribute to microcirculatory disturbances.
Purpose of the Study:
- To investigate the effects of isovolemic hemodilution with dextran 75 on cerebral perfusion, evoked responses, and hematological parameters in cats with acute intracranial hypertension.
- To assess the protective role of dextran 75 in mitigating microcirculatory dysfunction.
Main Methods:
- Acute intracranial hypertension was induced using an epidural balloon in cats.
- Animals underwent isovolemic hemodilution with dextran 75 after intracranial pressure relief.
- Cerebral perfusion, somatosensory evoked responses, and hematological parameters were measured.
Main Results:
- Dextran 75 infusion significantly improved cerebral perfusion compared to controls (11% vs. 30% impairment).
- Platelet aggregability and erythrocyte deformability were significantly restored in the dextran-infused group.
- Platelet volume increased during hypertension, correlating with decreased aggregability, suggesting activation.
Conclusions:
- Intravascular factors, including platelet aggregates and reduced erythrocyte deformability, play a critical role in microcirculatory disturbances following acute intracranial hypertension.
- Dextran 75 offers a protective effect by inhibiting platelet activation and through hemodilution, thereby improving microcirculation.
Abstract:
The authors have studied the effect of acute intracranial hypertension produced by placement of an epidural balloon (control group) in cats, on cerebral perfusion, evoked responses, and hematological parameters. These elements were measured in similarly injured animals which underwent isovolemic hemodilution with dextran 75, after relief of intracranial hypertension. Four hours after balloon deflation, perfusion was markedly impaired in 30% of the control group, and was reduced to 11% in the dextran-infused group. The suppressed N1 amplitude of somatosensory evoked responses on the compression side, the reduced platelet aggregability, and the erythrocyte-deformability by intracranial hypertension were all significantly more restored in the dextran-infused group after decompression. The percentage of platelets with volumes between 21.75 and 48.75 cu mu (normal 9.75 to 12.75 cu mu) significantly increased after decompression. Activation of platelets during intracranial hypertension leads to an increase in platelet volume from platelet aggregation, and correlates with a decrease in platelet aggregability. It was also suggested that reduction of erythrocyte deformability was not caused by erythrocyte aggregation. The authors emphasize the role of intravascular factors such as vascular obstruction by platelet aggregates, and difficulty in passage of erythrocytes through capillaries due to reduced deformability, in the disturbance of the microcirculation following acute intracranial hypertension. The protective effect of dextran 75 by inhibition of platelets as well as hemodilution is stressed.